Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 13Prostatic Neoplasms 11Leukemia 11Breast Neoplasms 11Melanoma 8Lymphoma 8Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Neoplasm Metastasis 6Myelodysplastic Syndromes 6Multiple Myeloma 6Leukemia, Myeloid, Acute 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Fallopian Tube Neoplasms 4Breast Neoplasms, Male 4Lymphoma, Follicular 3Kidney Neoplasms 3Hodgkin Disease 3Glioma 3Carcinoma, Renal Cell 3Osteosarcoma 2Neoplasms, Plasma Cell 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2

Interventions

Doxorubicin 62Ifosfamide 39Gemcitabine 29Radiotherapy 27Filgrastim 27Cyclophosphamide 26Docetaxel 19Vincristine 18pembrolizumab 17Etoposide 17pazopanib 16Cisplatin 16Nivolumab 15Trabectedin 14apatinib 13Magnetic Resonance Spectroscopy 13Carboplatin 12Irinotecan 11Bevacizumab 11anlotinib 10Temozolomide 10Surgical Procedures, Operative 10Sirolimus 10camrelizumab 9Sorafenib 9Paclitaxel 9Ipilimumab 9Injections 9Dactinomycin 9Topotecan 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00066365 2015-03-30

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma

Children's Oncology Group

Phase 2 Completed
49 enrolled 21 charts
Sarcoma

Neoplasm Metastasis, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡